127 related articles for article (PubMed ID: 9614383)
1. CD44 expression in normal, hyperplastic, and malignant endometrium.
Saegusa M; Hashimura M; Okayasu I
J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression.
Saegusa M; Machida D; Hashimura M; Okayasu I
J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
4. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
5. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
6. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
[TBL] [Abstract][Full Text] [Related]
8. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
10. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
Saegusa M; Hashimura M; Yoshida T; Okayasu I
Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas.
Saegusa M; Kamata Y; Isono M; Okayasu I
J Pathol; 1996 Nov; 180(3):275-82. PubMed ID: 8958805
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
14. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
15. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.
Kuo DY; Mallick S; Shen HJ; DeVictoria C; Jones J; Fields AL; Goldberg GL; Runowicz CD; Horwitz SB
Clin Cancer Res; 1996 Dec; 2(12):1981-92. PubMed ID: 9816157
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of metallothionein in endometrial lesions.
Ioachim EE; Kitsiou E; Carassavoglou C; Stefanaki S; Agnantis NJ
J Pathol; 2000 Jul; 191(3):269-73. PubMed ID: 10878548
[TBL] [Abstract][Full Text] [Related]
18. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
Taylor LJ; Jackson TL; Reid JG; Duffy SR
BJOG; 2003 Sep; 110(9):794-8. PubMed ID: 14511960
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
[TBL] [Abstract][Full Text] [Related]
20. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
